Slide 1: Executive Summary

Introduction

Slide 2: Uses of IVD Equipments

Slide 3: Segmentation of Product by Size of Equipment

Slide 4: Value Chain of IVD

Market Overview

Slide 5: In Vitro Diagnostics - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Market Segmentation (Value-Wise: 2011)

Slide 6: In Vitro Diagnostics Instruments - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), In Vitro Diagnostics Reagents - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e)

Slide 7: Immunochemistry - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Market Segmentation (Value-Wise: 2011)

Slide 8: Immunochemistry Instruments- Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Immunochemistry Reagents - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e)

Slide 9: Elisa Kits - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Rapid Tests - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e)

Slide 10: Biochemistry - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Biochemistry Instruments Segmentation (Value-Wise: 2011)

Slide 11: Biochemistry Instruments - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Biochemistry Reagents - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e)

Slide 12: Hematology - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Hematology Instruments Segmentation (Value-Wise: 2011)

Slide 13: Hematology Instruments - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Hematology Reagents - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e)

Slide 14: Hematology - Geographic Distribution (Value-Wise: 2011)

Slide 15: Microbiology - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Market Segmentation (Value-Wise: 2011)

Slide 16: Microbiology Instruments - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Microbiology Reagents - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e)

Slide 17: Blood Gas & Electrolyte - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Blood Gas & Electrolyte Instruments Segmentation (Value-Wise: 2011)

Slide 18: Blood Gas & Electrolyte Instruments - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Blood Gas & Electrolyte Reagents - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e)

Slide 19: Molecular Diagnostics - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Molecular Diagnostics Instruments Segmentation (Value-Wise: 2011)

Slide 20: Molecular Diagnostics Instruments - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Molecular Diagnostics Reagents - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e)

Slide 21: Urinalysis - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Urinalysis Instruments Segmentation (Value-Wise: 2011)

Slide 22: Urinalysis Instruments - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Urinalysis Reagents - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e)

Slide 23: Coagulation Analysis - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Coagulation Analysis Instruments Segmentation (Units Sold: 2011)

Slide 24: Coagulation Analysis Instruments - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e), Coagulation Analysis Reagents - Overview, Market Size and Growth (Value-Wise: 2011 - 2016e)

Drivers & Challenges

Slide 25: Summary

Slide 26-32: Drivers

Slide 33-34: Challenges

Laws and Guidelines

Slide 35: Directives Laid Down by Regulatory Bodies in Europe

Slide 36: Directives Laid Down by U.S. FDA

Slide 37: Directives Laid Down by Indian Government

Slide 38: Association of Diagnostics Manufacturers of India (ADMI)

Trends

Slide 39: Summary

Slide 40: Automation

Slide 41: Remote Data Acquisition, Enzyme-Linked Fluorescence Assay (ELFA)

Slide 42: Chemiluminescence Immunoassay (CLIA), Capillary Electrophoreses (CE) Based CLIA

Slide 43: Electrochemiluminescence Immunoassay (ECLIA)

Slide 44: Direct Access Testing, Rapid Accurate Quantification at Point of Care

Competition

Slide 45: Market Competition - Porter's Five Forces Analysis

Slide 46-51: Major Public Companies (Domestic)

Slide 52-65: Major Private Companies (Domestic)

Slide 66-89: Major Private Companies (Foreign)

Strategic Recommendation

Slide 90-91: Key Recommendations

Appendix

Slide 92: Appendix

Slide 93: Sources of Information

The in vitro diagnostics market in India has gathered momentum in the last few years. Several companies, both domestic as well as foreign are entering the business with enthusiasm due to the tremendous growth the industry has been experiencing. The steadily growing number of medical centers in the country along with the ever increasing patient population will result in a growing target base of consumers which in turn will result the market to exhibit steady growth in future.

The report begins with the introduction section which offers a brief insight to the concept of in vitro diagnostic equipments, along with a broad segmentation of the in vitro diagnostic equipments. The value chain of IVD has also been provided in this section which gives the progressive stages of manufacturing of IVD equipments. It then moves to the market overview section which provides an insight of the Indian in vitro diagnostics market, with highlight on the market size and growth. The market size has been provided for the overall IVD market as well as for the different segments such as immunochemistry, biochemistry, hematology, microbiology, blood gas & electrolyte, molecular diagnostics, urinalysis and coagulation analysis. Market size forecasts have been done for both the IVD equipments market as well as for the IVD reagents market. The same has also been repeated for each of the segments in the market.

This is followed by an analysis of the drivers leading to growth in the industry. This include high patient population growth rate, increasing number of hospitals and diagnostic labs, innovation by pharmaceutical companies, unhealthy lifestyle leading to chronic diseases, demand for cost effective, faster and sensitive results, increased affluence and increased healthcare awareness. The main challenges to the market include faulty regulations leading to disorientation of IVD products and prevalence of laboratories without accreditation. The next section elaborates the laws and guidelines laid down by the regulatory bodies of the different countries that draw attention to the lack of regulations in India. This is followed by a section on the major trends in the IVD market. It includes automation, remote data acquisition, enzyme-linked fluorescence assay (ELFA), chemiluminescence immunoassay (CLIA), capillary electrophoreses (CE) based CLIA, electrochemiluminescence immunoassay (ECLIA), direct access testing and rapid accurate quantification at point of care.

The competition section provides an overview of the in vitro diagnostic equipment manufacturers in India. It includes an elaborate profile of the major players in the market along with their financial analysis. The Porters Five Forces Analysis for the industry has also been incorporated for a brief but effective understanding of the market scenario. At the end of the report a strategic recommendations created after a thorough analysis of the industry has been provided. These recommendations focus on some effective strategic decisions which can be taken up by companies to increase their market shares.